UBS Group AG

Holdings History for Kymera Therapeutics, Inc. - Common Stock (KYMR)

Symbol: KYMR on Nasdaq
Investment type: Equity / Common Stock

Shares, Excluding Options vs Price

Value, Excluding Options

Holdings date	Weight	Change	Value $	Shares	Change	Activity %	Price	All Holders
31 Dec 2025	0.01%	+0%	$57,348,460	737,032	+88,314	+14%	$77.81	Q4 2025
30 Sep 2025	0.01%	+0%	$36,717,439	648,718	+90,984	+16%	$56.60	Q3 2025
30 Jun 2025	0.01%	-0%	$24,339,512	557,734	-35,872	-6%	$43.64	Q2 2025
31 Mar 2025	0%	+0%	$16,246,996	593,606	+123,764		$27.37	Q1 2025
31 Dec 2024	0%	+0%	$18,901,743	469,842	+252,223	+116%	$40.23	Q4 2024
30 Sep 2024	0%	+0%	$10,299,908	217,619	+7,318	+3.5%	$47.33	Q3 2024
30 Jun 2024	0%	-0%	$6,277,485	210,301	-86,379	-29%	$29.85	Q2 2024
31 Mar 2024	0%	-0%	$11,926,536	296,680	-3,783	-1.3%	$40.20	Q1 2024
31 Dec 2023	0%	+0%	$7,649,788	300,463	+137,704	+85%	$25.46	Q4 2023
30 Sep 2023	0%	-0%	$2,262,350	162,759	-77,957	-32%	$13.90	Q3 2023
30 Jun 2023	0%	+0%	$5,534,060	240,716	+55,421	+30%	$22.99	Q2 2023
31 Mar 2023	0%	-0%	$5,490,290	185,295	-17,466	-8.6%	$29.63	Q1 2023
31 Dec 2022	0%	+0%	$5,060,914	202,761	+153,076	+308%	$24.96	Q4 2022
30 Sep 2022	0%	-0%	$1,082,000	49,685	-61,784	-55%	$21.78	Q3 2022
30 Jun 2022	0%	-0%	$2,194,000	111,469	-24,621	-18%	$19.68	Q2 2022
31 Mar 2022	0%	+0%	$5,759,000	136,090	+66,974	+97%	$42.32	Q1 2022
31 Dec 2021	0%	+0%	$4,388,000	69,116	+55,873	+422%	$63.49	Q4 2021
30 Sep 2021	0%	-0%	$778,000	13,243	-13,297	-50%	$58.75	Q3 2021
30 Jun 2021	0%	+0%	$1,287,000	26,540	+1,098	+4.3%	$48.49	Q2 2021
31 Mar 2021	0%	+0%	$989,000	25,442	+21,829	+604%	$38.87	Q1 2021
31 Dec 2020	0%	+0%	$224,000	3,613	+3,382	+1464%	$62.00	Q4 2020
30 Sep 2020	0%	+0%	$7,000	231	+231	NEW	$30.30	Q3 2020

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.